BioMarin Pharmaceutical Inc (BMRN): Shares Outstanding

Annual figures by period end, from SEC filings.

192.30M
As of 2025-12-31
193.54M
As of 2026-06-30
+1.1%
3-year compound annual growth
+1.1%
5-year compound annual growth
+1.8%
10-year compound annual growth
2009-12-31: 100.96M2010-12-31: 110.63M2011-12-31: 114.79M2012-12-31: 125.81M2013-12-31: 143.46M2014-12-31: 149.09M2015-12-31: 161.53M2016-12-31: 172.65M2017-12-31: 175.84M2018-12-31: 178.25M2019-12-31: 179.84M2020-12-31: 181.74M2021-12-31: 183.91M2022-12-31: 186.25M2023-12-31: 188.60M2024-12-31: 190.76M2025-12-31: 192.30M192.30M
2009-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31192.30M+0.8%2026-02-26, Balance as of period end
2024-12-31190.76M+1.1%2026-02-26, Balance as of period end
2023-12-31188.60M+1.3%2025-02-24, Balance as of period end
2022-12-31186.25M+1.3%2024-02-26, Balance as of period end
2021-12-31183.91M+1.2%2023-02-27, Balance as of period end
2020-12-31181.74M+1.1%2022-02-25, Balance as of period end
2019-12-31179.84M+0.9%2021-02-26, Balance as of period end
2018-12-31178.25M+1.4%2020-02-27, Balance as of period end
2017-12-31175.84M+1.9%2019-02-28, Balance as of period end
2016-12-31172.65M+6.9%2018-02-26, Balance as of period end
2015-12-31161.53M+8.3%2017-02-27, Balance as of period end
2014-12-31149.09M+3.9%2016-02-29, Balance as of period end
2013-12-31143.46M+14.0%2015-03-02, Balance as of period end
2012-12-31125.81M+9.6%2014-02-26, Balance as of period end
2011-12-31114.79M+3.8%2013-02-26, Balance as of period end
2010-12-31110.63M+9.6%2012-02-22, Balance as of period end
2009-12-31100.96Mn/a2011-02-24, Balance as of period end